Responses
Clinical Trials
CT-02 Features of patients screened for calibrate (rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis); hypogammaglobulinemia is frequent in patients with marked elevation of urinary protein
Compose a Response to This Article
Other responses
No responses have been published for this article.